• Users Online: 392
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2021  |  Volume : 12  |  Issue : 2  |  Page : 59-65

COVID-19 vaccines and their potential use in patients with hematological malignancies

1 King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
2 Department of Pathology and Laboratory Medicine
3 Department of Oncology and Hematology

Correspondence Address:
Dr. Ashraf Dada
Department of Pathology, King Faisal Specialist Hospital & Research Center, Jeddah
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/joah.joah_28_21

Rights and Permissions

Many uncertainties exist regarding COVID-19 vaccination in patients undergoing treatment for hematological malignancies. We intend the illustrate the various types of COVID-19 vaccine currently in use and their mechanism of action. We have complied, recommendations for COVID-19 vaccination in patients suffering with specific hematological malignancies and those undergoing HCT and CAR-T cell therapy in this review. We have also discussed the available safety data for COVID-19 vaccination in the immunocompromised population.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded157    
    Comments [Add]    

Recommend this journal